YS Biopharma appoints new Directors
The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024
The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024
Launches collaborative centre for translational research in head and neck cancer
Ayush is expanding beyond wellness to therapeutic wellness
4 FDA clearances & 61 EU MDR CE tags achieved for AI in 18 months
Additionally, an MoU was signed between the Dental Council of India and Quality Council of India for the assessment and rating of undergraduate dental colleges
About 75% of all primary liver cancers in adults are HCC and up to 30% of HCC patients are eligible for embolisation
This Phase III clinical trial is a randomized, double-blind, placebo-controlled, multicenter clinical trial in China to evaluate the safety and efficacy of ASC40
The initiative is a response to the rising incidents of heart attacks and cardiac arrests in the state
An accomplished R&D leader and champion of the application of AI to drug discovery
Subscribe To Our Newsletter & Stay Updated